IP Library Assignment 065175/0044
Patent Assignment
Reel/Frame 065175/0044

Assignment of Assignor's Interest

Recorded: 2023-10-10 Pages: 3
Assignor
BRAVO GONZALEZ, ROBERTO CARLOS
Executed: 2017-01-19
Assignee
TILLOTTS PHARMA AG
BASLERSTRASSE 15, RHEINFELDEN, 4310, SWITZERLAND
Covered Property (1)
Eflornithine and Sulindac, Fixed Dose Combination Formulation
Application: 18/055,494 →
Publication: US 2023/0172887
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 10, 2023
From: DUCASSOU, JEAN
To: SANOFI WINTHROP INDUSTRIE
Reel/Frame 065174/0989 →
Assignment of Assignor's Interest Oct 10, 2023
From: SHANNON, PATRICK
To: CANCER PREVENTION PHARMACEUTICALS, INC.
Reel/Frame 065175/0107 →
Assignment of Assignor's Interest Oct 10, 2023
From: SANOFI WINTHROP INDUSTRIE S.A.
To: CANCER PREVENTION PHARMACEUTICALS, INC.
Reel/Frame 065175/0153 →
Assignment of Assignor's Interest Oct 10, 2023
From: TILLOTTS PHARMA AG
To: CANCER PREVENTION PHARMACEUTICALS, INC.
Reel/Frame 065175/0215 →
Assignment of Assignor's Interest Oct 30, 2025
From: PANBELA THERAPEUTICS, INC.; PANBELA RESEARCH, INC.; CANCER PREVENTION PHARMACEUTICALS, INC.
To: CREATIVE PLANNING BUSINESS ALLIANCE LLC
Reel/Frame 072735/0859 →
Assignment of Assignor's Interest Nov 3, 2025
From: CREATIVE PLANNING BUSINESS ALLIANCE, LLC
To: USWM, LLC
Reel/Frame 072766/0028 →